41150148 | 17/07/2024 18:23:26 |
|
|
Journal of periodontology, 2020, 91 5, 638 650 added to CENTRAL 30 September 2020 2020 Issue 09 brand name cialis online Patients receiving trastuzumab should have a baseline LVEF measurement immediately prior to initiation of therapy; LVEF measurements every 3 months during and upon completion of therapy; subsequent LVEF measurements at 4 week intervals if trastuzumab is withheld for significant LV cardiac dysfunction; and LVEF measurements every 6 months for at least 2 years following completion of therapy |
|
Телефон: stineve@envelopelink.xyz |
Контактная информация: ominivyVD |
|
Отправить сообщение
|
|
|
|